The_DT
transcriptionally_RB
active_JJ
factors_NNS
mediating_VBG
the_DT
effect_NN
of_IN
the_DT
HTLV-I_NN
Tax_NN
transactivator_NN
on_IN
the_DT
IL-2R_NN
alpha_NN
kappa_NN
B_NN
enhancer_NN
include_VBP
the_DT
product_NN
of_IN
the_DT
c-rel_NN
proto-oncogene_NN
._.

The_DT
transactivator_NN
HTLV-I_NN
Tax_NN
activates_VBZ
the_DT
promoter_NN
of_IN
the_DT
gene_NN
coding_VBG
for_IN
the_DT
interleukin_NN
2_CD
alpha-chain_NN
receptor_NN
-LRB-_-LRB-
IL-2R_NN
alpha_NN
-RRB-_-RRB-
via_IN
a_DT
kappa_NN
B_NN
site_NN
that_WDT
can_MD
bind_VB
several_JJ
protein_NN
species_NNS
of_IN
the_DT
rel_NN
family_NN
._.

Tax1_NN
strongly_RB
activates_VBZ
the_DT
enhancer_NN
activity_NN
of_IN
this_DT
motif_NN
,_,
in_IN
both_CC
epithelial_JJ
HeLa_NN
and_CC
lymphoid_JJ
Jurkat_NN
cells_NNS
._.

This_DT
activation_NN
was_VBD
not_RB
observed_VBN
in_IN
undifferentiated_JJ
embryocarcinoma_NN
F9_NN
cells_NNS
._.

Overexpression_NN
of_IN
the_DT
p50_NN
,_,
p65_NN
and_CC
Rel_NN
proteins_NNS
in_IN
these_DT
cells_NNS
showed_VBD
that_IN
significant_JJ
activation_NN
of_IN
the_DT
IL-2R_NN
alpha_NN
kappa_NN
B_NN
site_NN
was_VBD
observed_VBN
only_RB
with_IN
Rel_NN
and_CC
Rel_NN
plus_CC
p65_NN
._.

Moreover_RB
,_,
whereas_IN
both_CC
Tax_NN
and_CC
phorbol_NN
12-myristate_NN
13-acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
are_VBP
able_JJ
to_TO
efficiently_RB
induce_VB
the_DT
binding_NN
of_IN
NF-kappa_NN
B_NN
to_TO
the_DT
IL-2R_NN
alpha_NN
kappa_NN
B_NN
site_NN
,_,
PMA_NN
is_VBZ
functionally_RB
inactive_JJ
._.

Using_VBG
the_DT
DNA_NN
affinity_NN
precipitation_NN
assay_NN
,_,
we_PRP
observed_VBD
that_IN
Tax1_NN
is_VBZ
able_JJ
to_TO
efficiently_RB
induce_VB
the_DT
binding_NN
of_IN
Rel_NN
,_,
whereas_IN
PMA_NN
is_VBZ
not_RB
._.

This_DT
established_VBD
a_DT
clear_JJ
difference_NN
between_IN
both_DT
stimuli_NNS
,_,
indicating_VBG
that_IN
Rel_NN
is_VBZ
the_DT
functionally_RB
active_JJ
factor_NN
._.

We_PRP
conclude_VBP
from_IN
these_DT
results_NNS
that_IN
the_DT
functional_JJ
activity_NN
of_IN
members_NNS
of_IN
the_DT
rel_NN
family_NN
is_VBZ
regulated_VBN
by_IN
their_PRP$
interaction_NN
with_IN
DNA_NN
and_CC
that_IN
Rel_NN
can_MD
be_VB
a_DT
potent_JJ
transcriptional_JJ
activator_NN
on_IN
specific_JJ
kappa_NN
B_NN
sites_NNS
._.

